Jerry Bagel
VA New Jersey Health Care System(US)Navitas Systems (United States)(US)Windsor Dermatology(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical studies and practices
Most-Cited Works
- → Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis(2015)792 cited
- → Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial(2022)261 cited
- → Bimekizumab versus Adalimumab in Plaque Psoriasis(2021)223 cited
- → From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis(2016)182 cited
- → National Psoriasis Foundation Clinical Consensus on Disease Severity(2007)173 cited
- → Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis(2021)170 cited